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The effects of varying recovery modes and the influence of preexercise sodium bicarbonate and carbohydrate ingestion on repeated
high intensity performance, acid-base response, and recoverywere analyzed in 12well-trainedmales.They completed three repeated
high intensity running bouts to exhaustion with intervening recovery periods of 25min under the following conditions: sodium
bicarbonate, active recovery (BIC); carbohydrate ingestion, active recovery (CHO); placebo ingestion, active recovery (ACTIVE);
placebo ingestion, passive recovery (PASSIVE). Blood lactate (BLa), blood gases, heart rate, and time to exhaustion were collected.
The three high intensity bouts had a duration of 138 ± 9, 124 ± 6, and 121 ± 6 s demonstrating a decrease from bout 1 to bout 3.
Supplementation strategy had no effect on performance in the first bout, even with differences in pH and bicarbonate (HCO
3
−).
Repeated sprint performance was not affected by supplementation strategy when compared to ACTIVE, while PASSIVE resulted
in a more pronounced decrease in performance compared with all other interventions. BIC led to greater BLa, pH, and HCO
3
−
values compared with all other interventions, while for PASSIVE the opposite was found. BLa recovery was lowest in PASSIVE;
recovery in pH, and HCO
3
− was lower in PASSIVE and higher in BIC.
1. Background
Many sports (e.g., team sports such as soccer, rugby, and
ice hockey; combat sports like judo; endurance sports like
swimming, cycling, and running) often require short dura-
tionmaximal or near-maximal efforts to be regularly repeated
over an extended period of time [1]. In particular, the cross-
country skiing sprint competitions have four maximal bouts
with durations of 2–5 minutes within 2-3 hrs (including the
qualification bout). In the finals, the skiers have to reproduce
maximal performance over 3 bouts with only 10–25min rest
in between [2]. Therefore, understanding the physiological
load and the recovery kinetics of various physiological
parameters (e.g., bloodpH, blood lactate (BLa), etc.) and their
effects on subsequent repeated performance is essential.
During a sprint as short as 30 s, muscle glycogen stores
are supposed to be partially consumed and, at the end
of long duration training (60–90min) that involves high,
moderate, and low bouts of exercise, muscle glycogen will
be dramatically reduced or even depleted [3]. In a simulated
alpine skiing slalom training with 16 times 45 s runs (one run
every 20min), it was demonstrated that after the fourth run
the intramuscular glycogen store was reduced by 30% and
after 16 runs by 71%, especially in type 1 fibers [4]. Sto¨ggl et al.
[2] demonstrated that, during a cross-country skiing sprint,
performance and peak BLa decreased from heat to heat
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and the magnitude of BLa was positively related with sprint
performance. Based on their results, both Sto¨ggl et al. [2] and
Vogt et al. [4] recommended carbohydrate supplementation
prior to, during, or after the race/training.
Several studies showed that ergogenic supplements posi-
tively affected sprint performance, aswell as postperformance
recovery (e.g., [5–7]). Carbohydrate (CHO) based supple-
ments are probably the most common. There is an ongoing
debate among coaches and athletes concerningwhether CHO
supplementation during repeated high intensity sprint com-
petitions is a solution (e.g., among cross-country skiing sprint
skiers). However, research on intermittent or high intensity
and repeated sprint ability together with CHO loading or
supplementation is sparse [8, 9]. Supplementation with CHO
prior to or during a time trial resulted in performance
improvements due to an increase in CHO oxidation and
maintained plasma glucose levels [10].
Additionally, the use of sodium bicarbonate as one of
the major buffering agents used to diminish the supposed
negative effects of acidosis is common [11]. Recent research
has shown that ingesting sodium bicarbonate may enhance
aspects of sprint performance such as power output, total
anaerobic work, and delaying fatigue [11, 12], though results
are not consistent. A recentmeta-analysis revealed that inges-
tion of bicarbonate improves mean power by 1.7% (±2.0%) in
high intensity races of short duration [13]. Lavender and Bird
[14] and Bishop et al. [15] concluded that sodium bicarbonate
supplementation improves power output levels in repeated
short duration sprints (e.g., 10 times 10 s sprints with 50 s
recovery, or 5 times 6 s all-out sprints every 30 s). Bishop
et al. [15] suggested that the improved performance was a
result of the greater extracellular buffer concentration by
sodium bicarbonate ingestion increasing H+ efflux from the
muscles into the blood and an increased anaerobic energy
contribution. Research on repeated high intensity bouts of
longer duration and with longer recovery in between is
lacking.
Finally, the role of the recovery mode during repeated
high intensity activity is also a topic of debate. Active
recovery (pedaling at 20% VO
2max) has been shown to
facilitate performance (4 times 110% peak performance to
exhaustion with 5min recovery in between bouts) compared
to passive recovery [16], while the opposite was found in
intermittent exercise of 15 s high intensity versus 15 s recovery
(40% VO
2max during active recovery) [17] and with no
differences between 3 times 110% peak power output to
exhaustion with 12min breaks (20% of maximal workload
during active recovery) in between [18]. Furthermore, passive
recovery is expected to favor PCr resynthesis during shorter
recovery periods between bouts, for example, up to 2min
[7].
Therefore, the aim of the current study was to analyze the
effects of passive versus active recovery andhow carbohydrate
and sodium bicarbonate supplements influence performance
and recovery during three bouts of high intensity exercise
with recovery duration of 25minutes in between.The specific
hypotheses were that (a) active recovery facilitates repeated
performance, (b) acute sodium bicarbonate ingestion leads to
performance enhancement in each high intensity bout, and
(c) acute carbohydrate supplementation delays fatigue across
all three high intensity bouts.
2. Methods
2.1. Subjects. Twelve endurance-trained males (mean ± SD:
age = 32.8±3.8 yrs, body height = 1.78±0.06m, body weight
= 74 ± 6 kg, and VO
2max = 66.4 ± 5.2mL⋅min
−1
⋅ kg−1)
with backgrounds in running and cross-country skiing vol-
unteered to participate in this study.
2.2. Ethics Statement. Subjects were informed about the test
procedures and possible risks prior to giving their written
informed consent to participate.The research techniques and
experimental protocol were preapproved by the Local Ethics
Committee of the University of Salzburg, and the study was
performed in accordance with the Declaration of Helsinki.
2.3. Overall Design of the Study. Participants reported to the
laboratory at the same time of the day on four separate
test days with a minimum of 5 days, but no more than
8 days between trials. For all participants, all tests were
performed within 23 ± 3 days. Participants were advised not
to perform strenuous exercise within 72 hrs prior to each
trial and were asked to control, record, and duplicate food
intake 24 hrs prior to each trial (data collected and reviewed,
but not presented in this paper). Each test day included
a standardized warm-up followed by three all-out sprint
bouts running on a treadmill with fixed breaks of 25min in
between bouts (comparable with the competition mode in
sprint cross-country skiing). Each test had a total duration
of approximately 90min. On each test occasion the following
supplementation and recovery strategies were randomized
(counterbalanced using the Latin least squares design) in
a double-blind manner across the participants: (a) placebo
drink with no activity between sprint bouts (PASSIVE); (b)
placebo drink and low intensity running between sprint bouts
(ACTIVE); (c) carbohydrate mix and low intensity running
between sprint bouts (CHO); and (d) bicarbonate drink and
low intensity running between sprint bouts (BIC).
2.4. Supplementation. TheBIC drink was prepared according
to McNaughton [19] using 300mg/kg (body mass) bicar-
bonate and 2 cl artificial sweetener (saccharin) dissolved
in 6mL/kg (body mass) water. The CHO mixture was
an isotonic 5.5% solution, which consisted of 1.7% glu-
cose; 1.1% fructose; 0.6% maltose; 1.9% (higher) saccha-
ride and electrolytes (sodium: 61mg/100mL and potassium:
10mg/100mL) [20] with total CHO amount of 300mg/kg
(body mass). The placebo drink (PASSIVE and ACTIVE
group) consisted of artificial sweetener (saccharin) and
sodium chloride. For CHO, PASSIVE, and ACTIVE the
participants ingested 6mL/kg (body mass) of the respective
solution at arrival and the same amount throughout the
experiment.
2.5. Experimental Protocol. Participants reported to the labo-
ratory 100min before test start with no food intake 3 hrs prior
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Figure 1: Illustration of the general design of the study.
to the test start; they were instructed to be refrained from
caffeine and alcohol and be well-hydrated. Ten min after
arrival, two blood samples from the earlobe were taken to
determine resting values in blood lactate (BLa) and blood
gases. Directly afterwards (90min prior to the start of the
exercise protocol) the participants drank, according to the
randomized order, one of the three supplements [placebo
(PASSIVE, ACTIVE), CHO, and BIC]within a 10min period.
In addition, ten minutes prior to warm-up, as well as within
the breaks between the single bouts, participants drank
2mL/kg of CHO or placebo (for PASSIVE, ACTIVE, and
BIC). Another two blood samples for BLa and blood gases
were collected 3 minutes prior to start of the warm-up. The
CHO was administered throughout the protocol in order
to possibly enhance CHO oxidation and maintain plasma
glucose levels [10]. BIC supplementation was switched to
the placebo drink during the exercise, in order to prevent
possible gastrointestinal problems. The test started with a
standardized warm-up protocol of 15min, with 5min at
8 km/h at 1.5% grade, 5min at 8 km/h at 5% grade, and 3 times
30 s acceleration runs up to 16, 18, and 19 km/h at 5% grade
with 1min at 8 km/h in between the sprint runs. The warm-
up was finished with 1.5min at 8 km/h at 5% grade. In the
first minute, after warm-up, two blood samples were taken:
a blood sample for the determination of BLa and one for the
determination of blood gases. After a rest of 3min, the first
high intensity bout started with a fixed treadmill inclination
of 5% and a treadmill speed of 19 km/h. Participants were
asked to run as long as possible at this treadmill speed and
were maximally encouraged by the test team. The time to
exhaustion was taken as the performance parameter for each
sprint bout. The participants had no knowledge of the length
of time they were actually running. Even though time trial
tests were shown to have higher validity than a time to
exhaustion test [21], we decided to use this test concept based
on (1) high internal validity by maximal standardization of
the running test on an indoor treadmill and (2) prevention
of different pacing strategies during each of the four trials.
Furthermore, the participants were familiar with this test
procedure based on a reliability study prior to this experiment
(𝑛 = 15 including the same subjects of this study, intraclass
coefficient of 0.95; 𝑃 < 0.001 for maximal test duration).
After each bout, the participants had a 25min break
consisting of 5min rest followed by 17 min of either sitting
on a chair (PASSIVE) or low intensity running [∼65–70%
peak heart rate (HR)] on the treadmill at 6 km/h and a 1.5%
grade (ACTIVE, CHO, and BIC) and another 3min passive
rest prior to the second sprint bout. The same procedure was
repeated for the third sprint bout. Following each sprint bout
blood samples for BLa were taken in the 3rd, 5th, 7th, 10th,
and 25thmin and for blood gases in the 1st and 24thmin.
An overview on the entire protocol is illustrated in Figure 1.
All participants were securedwith a safety harness suspended
from the ceiling and attached to an emergency break.
2.6. Instruments. The participants’ HR was recorded
throughout all tests telemetrically (Suunto t6, Helsinki,
Finland) at 2 s intervals. The peak HR of each bout was used
for further statistical analysis. For BLa a 20𝜇L and for blood
gases a 150𝜇L blood sample from the hyperaemized right
earlobe were collected into a capillary tube (Eppendorf AG,
Hamburg, Germany). The BLa samples were immediately
analyzed amperometric-enzymatically (Biosen 5140, EKF-
Diagnostic GmbH, Magdeburg, Germany). The lactate
sensor was calibrated before each test and checked using a
lactate standard sample of 12mmol/L. Results within a range
of ±0.1mmol⋅L−1 were accepted. Blood gases were analyzed
using the Cobas b 221 system (Roche Diagnostics GmbH,
Mannheim, Germany). The system automatically performs a
system calibration every 24 hrs and a 1-p calibration every 30
minutes.
2.7. Statistical Analysis. All data were checked for normality
using Shapiro-Wilk’s test to exhibit a Gaussian distribution,
and the values are presented asmean± SD. For determination
of global differences betweenmeasured physiological param-
eters (BLa, pH, HCO
3
−, base excess (BE), PO
2
, and PCO
2
)
across the entire experiment (all three bouts including the
postrecovery values) a 4 × 5 repeated-measures ANOVA (4
interventions × 5 time points) was applied. For the variables
sprint bout time and the peak values of the measured
physiological parameters during or after sprint a 4 × 3
repeated-measuresANOVA(4 interventions× 3 sprint bouts)
was conducted. For determination of differences within the
single sprint bouts and the single recovery values an ANOVA
with repeated measures was used. In all cases a Bonferroni
post hoc analysis was applied. Correlations of performance in
the first bout to the peak values and recovery values in BLa
and pH Pearson’s product moment correlation coefficients
were calculated. Level of significance was set at 𝛼 < 0.05.
3. Results
Upon arrival at the laboratory, there were no differences indi-
cated for pH, lactate, HCO
3
−, BE, PO
2
, or PCO
2
between the
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four interventions (Table 1). Some participants did report
experiencing minor bloating and/or gastrointestinal stress
following the BIC (𝑛 = 2) and CHO (𝑛 = 1) within the
90min after ingestion timeperiod.However, these side effects
subsided by the time the warm-up started.
High intensity running performance reflected by the
sprint bout duration demonstrated amain effect for interven-
tion (mean of all three bouts) (PASSIVE: 122 ± 6 s; ACTIVE:
125 ± 5 s; CHO: 132 ± 8 s; BIC: 132 ± 9 s; 𝑃 = 0.031)
with no difference at bout 1, but lower performance in the
PASSIVE group at bout 2 compared with BIC (𝑃 = 0.048)
and at bout 3 compared with all other groups (𝑃 = 0.009 to
0.012).This was also reflected by an interaction effect towards
greater decreases in running performance with PASSIVE
compared with BIC from bout 1 to bout 2 (𝑃 = 0.05) and
when compared with BIC and CHO from bout 1 to bout 3
(PASSIVE: −30.5 ± 17.9 s; CHO: −14.5 ± 13.2 s; BIC −9.2 ±
16.9 s; 𝑃 = 0.029). There was a main effect for factor time
(𝑃 = 0.008) demonstrating a tendency towards a decrease
in performance (−10%) from bout 1 to bout 2 (138 ± 9 s
versus 124 ± 6 s, 𝑃 = 0.066) and when comparing bout 1
with bout 3 (−12%: 138 ± 9 s versus 121 ± 6 s, 𝑃 = 0.007)
(Figure 2(a)).
Peak HRwithin each bout demonstrated a main effect for
intervention (PASSIVE: 181 ± 2 bpm; ACTIVE: 185 ± 2 bpm;
CHO: 184±2 bpm; BIC: 186±2 bpm; 𝑃 = 0.009) with higher
values in BIC compared with PASSIVE (𝑃 = 0.026) and
a tendency towards higher values in ACTIVE compared with
PASSIVE (𝑃 = 0.062). When analyzing each bout separately,
there was no difference between interventions at bout 1, while
at both bout 2 (𝑃 = 0.015) and bout 3 (𝑃 < 0.001) PASSIVE
was lower in peak heart rate compared with all other
interventions. A main effect was also found for factor time
with a reduction in peak HR across bouts (bout 1: 189 ±
2 bpm; bout 2: 182 ± 2 bpm; bout 3: 181 ± 2 bpm; 𝑃 <
0.001). An interaction of time × intervention was found
(𝑃 < 0.001), with greater decreases from bout 1 to bout 2
and bout 1 to bout 3 in PASSIVE compared with all other
interventions.
3.1. Peak Values after Sprint Bout. Physiological parameters
across the entire experiment for all four interventions are
illustrated in Figure 2 and Table 1. Peak BLa values demon-
strated a main effect for intervention (𝑃 = 0.002), leading
to greater BLa values in the BIC group compared with CHO
and ACTIVE, with no change across time. An interaction
effect between time and intervention (𝑃 = 0.045) was found,
demonstrating a decrease in BLa for ACTIVE and CHO
compared with stable values in BIC and PASSIVE. Postbout
blood pH values demonstrated main effects for intervention
(𝑃 < 0.001) with no time or interaction effect with higher
values in BIC compared with all other interventions. When
examining the postbout HCO
3
− and BE values there was a
main effect for intervention and time (all 𝑃 < 0.001) with
higher values for BIC compared with all other interventions
and a decrease in the values from bout to bout. Postbout
PO
2
values reflected no differences between interventions
and no change across sprint bouts. PCO
2
was greater in BIC
compared with all other interventions (𝑃 = 0.016 to 0.050)
with a reduction from bout 1 to bout 2 (𝑃 = 0.014) and bout
1 to bout 3 (𝑃 = 0.006).
3.2. Recovery Values after 25min Recovery. Relative to the
BLa value after the 25min recovery, therewas amain effect for
intervention (𝑃 < 0.001) with no time effect, which demon-
strated higher BLa values in PASSIVE compared with all
other interventions. In regard to BLa recovery (delta changes
from the peak values to the values at the end of the 25min
recovery phase), a main effect for intervention was found
(PASSIVE: −4.8 ± 0.3mmol/L; ACTIVE: −8.7 ± 0.4mmol/L;
CHO:−8.6±0.2mmol/L; BIC:−9.5 ± 0.3mmol/L;𝑃 < 0.001)
with lowest reduction in BLa in PASSIVE compared with all
other interventions and a trend towards greater reduction
in BIC compared with CHO (𝑃 = 0.059). Furthermore,
CHO had lower recovery compared with BIC (𝑃 = 0.037).
Blood pH, HCO
3
−, and BE values after the 25min recovery
demonstrated a main effect for intervention (all 𝑃 < 0.001)
with no time or interaction effect with lower values in
PASSIVE and higher values in BIC, respectively, compared
with all other interventions. There was no difference in PO
2
values after 25min recovery, while for PCO
2
PASSIVE was
lower compared with all other interventions (𝑃 = 0.010 to
0.050).
3.3. Correlations. Performance in the first bout (test dura-
tion) was correlated with peak BLa, peak pH, and the
recovery values after 25min for BLa and pH for PASSIVE
(𝑟 = 0.74, −0.88, 0.88, and −0.94; all 𝑃 < 0.001), ACTIVE
(𝑟 = 0.73, −0.82, 0.73, and −0.69; all 𝑃 < 0.05), and CHO
(𝑟 = 0.65, −0.72, 0.54, and−0.63; all 𝑃 < 0.05). In the BIC
situation only peak pH and pH after 25min recovery were
related with performance in the first bout (𝑟 = −0.63, 𝑃 <
0.05; 𝑟 = −0.80, 𝑃 < 0.01). No such correlation was found for
peak and recovery BLa (𝑟 = 0.41, 0.53; both 𝑃 > 0.05).
4. Discussion
The main findings of the current study were that (a) the
supplementation strategy had no effect on the performance
in the first sprint bout, even though marked differences
in pH, BE, and HCO
3
− were found, particularly in the
BIC intervention; (b) repeated sprint bout performance was
not affected by supplementation strategy when compared to
the placebo active condition (ACTIVE), while placebo with
passive rest between the bouts (PASSIVE) resulted in a more
pronounced decrease in performance; (c) BIC led to greater
BLa, pH, HCO
3
−, and BE values across the entire experiment
comparedwith all other interventions, while for PASSIVE the
opposite was found; (d) BLa values did not change across
repeated sprint bouts, though peak HR and performance
dropped; (e) though globally not changed, BLa remained
constant in BIC and PASSIVE while it decreased in CHO
and ACTIVE across sprint bouts; (f) BLa recovery during the
25min recovery periods was lowest in PASSIVE compared
with all other interventions; recovery in pH, BE, and HCO
3
−
was lower in PASSIVE and higher in BIC compared with all
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Table 1: Blood lactate, blood gases, pH, and base excess (BE) associated with four interventions at rest, pre-warm-up, post-warm-up, and
before and after the three high intensity bouts (mean ± SD).
Rest Before warm-up Warm-up After bout 1 Before bout 2 After bout 2 Before bout 3 After bout 3
Blood lactate
(mmol/L)
PASSIVE 1.2 ± 0.3 1.3 ± 0.2 3.3 ± 1.6 14.8 ± 2.0 9.8 ± 2.5∗ 15.2 ± 2.2 10.5 ± 2.7∗ 14.4 ± 2.5
ACTIVE 1.4 ± 0.6 1.3 ± 0.3 3.0 ± 1.2 14.2 ± 2.8 5.4 ± 2.4 13.6 ± 1.9 5.0 ± 1.5 13.0 ± 1.8
CHO 1.2 ± 0.2 1.3 ± 0.2 3.1 ± 1.4 15.0 ± 2.0 6.2 ± 2.2 14.1 ± 2.3 5.8 ± 1.8 14.0 ± 2.0
BIC 1.2 ± 0.4 1.4 ± 0.5 3.7 ± 1.6 15.6 ± 2.4 6.0 ± 1.5 15.6 ± 2.1† 6.3.5 ± 1.6‡ 15.5 ± 1.8†‡
pH
PASSIVE 7.41 ± 0.02 7.41 ± 0.01 7.41 ± 0.02 7.16 ± 0.04 7.29 ± 0.05∗ 7.16 ± 0.04 7.28 ± 0.06∗ 7.15 ± 0.06
ACTIVE 7.43 ± 0.02 7.43 ± 0.03 7.41 ± 0.03 7.18 ± 0.05 7.39 ± 0.04 7.19 ± 0.05 7.39 ± 0.05 7.19 ± 0.04
CHO 7.43 ± 0.02 7.43 ± 0.01 7.42 ± 0.02 7.16 ± 0.07 7.36 ± 0.05 7.19 ± 0.06 7.36 ± 0.06 7.17 ± 0.05
BIC 7.41 ± 0.01 7.47 ± 0.02∗ 7.44 ± 0.01‡$ 7.24 ± 0.06† 7.43 ± 0.04† 7.22 ± 0.06∗ 7.39 ± 0.05† 7.22 ± 0.04∗
HCO
3
−
(mmol/L)
PASSIVE 24.2 ± 1.3 24.0 ± 1.1 21.6 ± 1.7 12.0 ± 2.0 13.5 ± 3.0∗ 10.1 ± 1.9∗ 12.4 ± 2.0∗ 9.4 ± 2.3
ACTIVE 24.2 ± 1.7 24.4 ± 1.6 21.9 ± 1.7 13.0 ± 2.4 18.1 ± 3.3 11.4 ± 2.3 18.4 ± 2.1 11.8 ± 1.5
CHO 24.2 ± 1.2 24.1 ± 1.5 21.6 ± 2.2 12.2 ± 1.9 17.8 ± 2.9 11.9 ± 1.9 18.4 ± 2.5 11.5 ± 2.3
BIC 24.5 ± 1.4 24.3 ± 1.2 25.1 ± 2.7∗ 15.4 ± 2.9†$ 21.2 ± 1.8†$ 13.9 ± 2.0∗ 21.1 ± 2.8†$ 13.5 ± 2.6$
BE
(meq/L)
PASSIVE −1.7 ± 1.2 −1.5 ± 1.2 −4.4 ± 1.8 −16.8 ± 2.2 −13.4 ± 3.6∗ −18.6 ± 2.7∗ −14.7 ± 2.6∗ −19.7 ± 3.1
ACTIVE −1.6 ± 1.4 −1.6 ± 1.5 −4.1 ± 1.8 −15.5 ± 3.0 −8.2 ± 3.8 −17.0 ± 2.8 −7.7 ± 2.3 −16.5 ± 2.0
CHO −1.5 ± 1.3 −1.6 ± 1.2 −4.3 ± 2.3 −16.5 ± 2.4 −8.4 ± 3.3 −16.6 ± 2.6 −7.7 ± 2.8 −17.2 ± 3.0
BIC −1.4 ± 1.3 −1.1 ± 1.1 −0.6 ± 2.7∗ −12.6 ± 3.3†$ −4.3 ± 2.2†$ −13.9 ± 2.7∗ −3.9 ± 2.1†$ −14.3 ± 2.8†$
PO2
(mmHg)
PASSIVE 78.3 ± 5.7 78.5 ± 5.9 82.6 ± 4.4 93.2 ± 5.9 83.6 ± 7.9 95.8 ± 7.2 84.9 ± 8.5 98.2 ± 7.6
ACTIVE 81.4 ± 9.3 80.1 ± 8.3 82.0 ± 4.7 91.7 ± 9.8 79.4 ± 3.4 95.9 ± 4.8 78.5 ± 5.4 94.7 ± 6.2
CHO 83.3 ± 8.3 81.2 ± 8.1 84.7 ± 4.5 94.1 ± 5.5 81.0 ± 5.0 93.0 ± 4.1 77.0 ± 5.1 93.2 ± 6.0
BIC 81.7 ± 7.5 81.1 ± 7.7 80.0 ± 5.9 89.6 ± 6.1 77.3 ± 8.2 90.2 ± 7.0 77.2 ± 6.9 91.6 ± 5.0
PCO2
(mmHg)
PASSIVE 38.5 ± 2.2 38.7 ± 2.0 35.8 ± 2.1 34.2 ± 5.4 28.0 ± 3.2 28.8 ± 2.5∗ 26.7 ± 2.3∗ 28.4 ± 2.6
ACTIVE 37.9 ± 3.3 37.1 ± 3.5 36.3 ± 2.8 35.4 ± 4.7 32.2 ± 3.6 30.5 ± 3.6 32.0 ± 2.7 31.6 ± 2.9
CHO 37.8 ± 1.9 37.5 ± 1.1 35.7 ± 3.4 33.8 ± 4.9 31.7 ± 2.6 32.0 ± 1.8 32.2 ± 2.7 31.9 ± 3.1
BIC 39.0 ± 3.0 39.5 ± 3.7 38.5 ± 3.2 37.7 ± 5.9 33.3 ± 1.7$ 33.4 ± 2.9 33.8 ± 3.0 32.4 ± 4.2$
∗Different to all other interventions.
†Different to CHO.
‡Different to ACTIVE.
$Different to PASSIVE.
other interventions; and (g) performance in the first sprint
bout was related to higher peak BLa and lower pH values after
exercise and after the 25min recoverywithin all interventions
except for BIC where no correlations were found.
4.1. Passive versus Active Recovery. Motivated by the con-
trasting results of previous research on the effects of active
versus passive recovery, the current study supports that active
recovery during breaks of longer duration (i.e., 25min) is
a favorable strategy compared with passive recovery during
repeated high intensity bouts. Active recovery (pedaling at
20% VO
2max) has been shown to facilitate performance
compared to passive recovery in a protocol with 4 times at
110% of peak performance to exhaustion and 5min recov-
ery in between. This was based on an increase in aerobic
energy yield and a higher fractional contribution of aerobic
metabolism to total energy turnover [16]. Therefore, active
recovery may have favored an increased aerobic contribution
during the subsequent high intensity bouts and may have
promoted an increase in muscle blood flow, O
2
delivery, and
a correspondent increase in intracellular pH for all active
interventions [22, 23]. On the contrary, in another study
[17] during intermittent exercise of 15 s high intensity with
15 s recovery until exhaustion was reached, the passive rest
led to increased time to exhaustion compared with active
rest using intensity of 40% VO
2max based on lower muscle
oxygenation levels during active than during passive recov-
ery. Furthermore, despite comparable responses in acid-base
status as in the current study, performance was unaffected by
12min active versus passive recovery between 3 high intensity
(110% peak power output) bouts to exhaustion in the study
of Siegler et al. [18]. Another explanation for the reduced
performance in the PASSIVE situation in the current study
might be a decreased metabolic rate and/or priming of the
neuromuscular and muscle-tendon system prior to the high
intensity bouts.
The low active recovery intensity used in this studywas an
attempt to increase muscle blood flow while not interrupting
PCr resynthesis, since those stores are crucial for subsequent
efforts [24, 25]. When considering that the half time recovery
for PCr is rarely superior to 90 s during a passive recovery
[26], we expected a more than optimum reload of PCr in the
current study for both active and passive interventions.Thus,
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Figure 2: Development of running performance (a), blood lactate (b), and pH (c) across the entire experiment including resting values, post-
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with carbohydrate ingestion; BIC: active recovery with sodium bicarbonate ingestion. ∗Significant difference to specified intervention.
we may rule out its influence on performance in our bouts
without using invasive techniques. Accepting passive recov-
ery to be favored towards PCr resynthesis in short recovery
periods between bouts (e.g., up to 2min [7]) is probably not
imperative when using a much longer 25min rest period as
in the current study. Therefore, together with the findings
of Dorado et al. [16], the current study supports that active
recovery seems to lead to superior performance outcome in
repeated high intensity bouts when the recovery period is
at least 5min. Further research is warranted concerning the
detection of the actual turning point when active recovery
outperforms passive recovery and the type of exercise and
intensity used during active recovery.
4.2. Effects on Performance. Finding no performance dif-
ferences between the CHO, BIC, and placebo intervention
(ACTIVE), in contrast to other studies with shorter bout
durations and recovery periods (e.g., [5–7, 11, 12]), we con-
clude that for repeated high intensity performance to exhaus-
tion (bout duration ∼2min) with long recoveries (25min)
the length and activity mode of the recovery period may be
a more crucial variable than the acid-base status or possibly
enhanced glucose availability based on the CHO supplemen-
tation.This idea was previously proposed by Siegler et al. [7].
In order for bicarbonate supplementation to be effective, the
metabolic stress must be enough to decrease glycolytic activ-
ity and diminish PCr resynthesis and Ca2+ resequestering
in the cell so as to grant a decline in the force production.
Furthermore, it would be necessary to maintain this stress
situation until the next bout in order to possibly create a
significant difference in performance. Though differences in
pH for different active recovery strategies before the second
and third bouts were found in the current study, repeated
performance was not different between interventions with
active recovery.
Concerning CHO supplementation, neither performance
enhancement in the first bout nor increased fatigue resis-
tance across all three bouts can be confirmed. Therefore,
in agreement with earlier studies, CHO supplementation or
loading seems to have no effect on sprint performance and/or
high intensity exercise up to about 30min compared with
normal diets [27]. To our knowledge, there is only one study
demonstrating that a chronic application of carbohydrates
over five days resulted in an increase in high intensity perfor-
mance (e.g., repeated countermovement jump performance
with 10 jumps over 60 s) compared with a placebo [28]. The
current study is in line with the findings of Jenkins et al.
[3, 29], who demonstrated that there is no improvement in
performance while in a carbohydrate loaded state and when
ingesting glucose prior to the exercise during five 60 s all-
out cycling bouts separated by 5min of passive recovery
compared with a normal carbohydrate diet. The authors
questioned the ergogenic potential of consuming glucose
before supramaximal exercise [3]. Also Robinson et al. [30]
found no difference between the ingestion of carbohydrates
versus placebo during high intensity running (intensity at
100% VO
2max) over a duration comparable to that of the
current study. Therefore, the speculation of Sto¨ggl et al. [2]
that CHO supplementation might enhance performance in a
cross-country skiing sprint competition cannot be supported
based on the current findings. However, the finding that peak
BLa decreased frombout 1 to bout 2 and that themagnitude of
BLa values across the entire simulation was positively related
to cross-country skiing sprint performance is in line with
the findings of the current study where, in all active rest
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interventions except BIC, BLa decreased from bout 1 to bout
2 and also, in all but the BIC intervention, peak BLa was
related to sprint performance.This result might indicate that,
especially with BIC, participants show different responses
that might have diluted the group outcome. Finally, the
ergogenic effect of BLa as proposed by others [31–33] was not
noted in this experiment, as PASSIVE and BIC demonstrated
a higher prebout BLa but, respectively, lower and similar
performance compared with the other interventions.
5. Limitations
One limitation of the current study might be seen in the
collection of arterialized instead of arterial blood samples for
determination of blood gases. In a study of Sauty et al. [34]
it was demonstrated that the correlation coefficients between
arterial and arterialized blood samples for PO
2
and PCO
2
were high with 0.928 and 0.957 (both 𝑃 < 0.001). However,
arterialized earlobe PO
2
was lower than arterial PO
2
in most
cases, and the difference increased as arterial PO
2
increased.
Therefore, the absolute values of PO
2
in the current study
might underestimate the true PO
2
values. However, based on
the repeated measured design this fact might not affect the
basic outcome.
6. Conclusion
In summary, the findings of the current study show that when
successive high intensity maximal exhaustion bouts are sep-
arated by 25min of recovery, an active recovery coupled with
a preexercisemetabolic alkalosis or carbohydrate supplemen-
tation would not lead to detectable improvements in perfor-
mance as assessed by time to fatigue at high speed treadmill
running, regardless of sustaining blood buffering capacity. In
spite of a higher pH than the placebo condition in the case of
the bicarbonate supplementation intervention and supposed
higher glucose availability in carbohydrates supplementa-
tion, we found no significant difference in performance.
Only the application of active recovery led to enhanced
performance and attenuated fatigue when compared with the
passive recovery intervention. Future studies are needed to
gain deeper insight into the relationship between exercise
intensities and durations with recovery modes and recovery
intensities and supplementation after repeated high intensity
activity in order to improve performance or delay fatigue.
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